Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Shreyas Intermediates Limited operates in the basic materials sector, focusing on the production of specialty chemicals primarily for the pharmaceutical and agrochemical industries in India. The company has a competitive edge due to its established supplier relationships and a diverse product portfolio, although it currently faces challenges with negative margins.
Shreyas Intermediates generates revenue through the sale of specialty chemicals, leveraging its established relationships with key players in the pharmaceutical and agrochemical sectors. The company benefits from a relatively inelastic demand for its products, which allows for some pricing power despite current negative margins.
Fluctuations in raw material prices, particularly for petrochemicals
Changes in regulatory policies affecting the chemical industry in India
Demand shifts in the pharmaceutical sector, especially for generic drugs
Currency fluctuations impacting export revenues
Regulatory changes that could impose stricter environmental standards on chemical production
Technological advancements in alternative materials that could reduce demand for traditional chemicals
Increased competition from domestic and international specialty chemical producers
Potential pricing pressure from larger competitors with economies of scale
Negative operating margins leading to potential liquidity issues
Dependence on short-term financing for working capital needs
moderate - The company's performance is linked to industrial activity and consumer spending, particularly in the pharmaceutical and agrochemical sectors.
Rising interest rates could increase financing costs for Shreyas Intermediates, impacting its ability to invest in growth or manage existing debt.
minimal - The company has a manageable debt-to-equity ratio of 0.51, indicating limited reliance on external financing.
value - Investors may be attracted to the stock due to its low market cap relative to potential recovery in margins and revenue growth.
high - The stock has demonstrated significant volatility, with a 1-year return of -27.8%.